ERBB2 and neoplasm: Prominent examples include HER2, TROP2, folate receptor alpha (FRα), glucose transporter 1 (GLUT1), and various angiogenic receptors, all of which are not only associated with tumor growth and survival but also correlate with poor prognosis and increased metastatic potential [107,108,109,110,111].